Trend
DailyDowntrend (starting)
4 hourStrong Bullish
1 hourStrong Bullish
15 minSymmetric Triangle
5 minStrong Bullish
Daily trend turns up above $5.10
Key levels
Resistance$4.27
Resistance$3.92
Support$3.35
Support$2.82
Latest news & SEC filings
AnalystHC Wainwright keeps Buy rating on Inventiva, cuts price target
AnalystHC Wainwright Keeps Buy Rating on Inventiva, Cuts Price Target to $14
AnalystPiper Sandler keeps Buy rating and $26 target on Inventiva
All IVA news →Inventiva is a French drug developer working on treatments taken by mouth for a liver condition tied to metabolic problems, known as MASH. Its main candidate, lanifibranor, is being tested in late-stage trials, and the company also has partners handling development in China and Japan. Inventiva runs its own laboratory site in France and is listed on Euronext Paris and Nasdaq.
Based on the company's 20-F filed Apr 8, 2026.
Nasdaq · Healthcare
SEPT Low Target
$14.00
SEPT Mid Target
$19.50
SEPT High Target
$26.00
Analyst Consensus
$19.50
Thesis
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for IVA.
Start Free Trial →Valuation Verdict
UNDERVALUED
Methods Used
Analyst Consensus
Fair Value
$19.50
45
Moat Score
NARROW
1/9
Piotroski Score
-2.3
Altman Z-Score
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →Revenue YoY
-47.4%
3yr Revenue CAGR
26.1%
EPS Growth YoY
-26.79%
FCF Growth YoY
N/A%
Revenue Trend
STRONG
SEPT Investing tracks real-time dark pool institutional trades for IVA, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:00:02 | $3.80 | 1,900 | $$7K | BUY |
| 20:59:39 | $3.79 | 1,000 | $$4K | MIDPOINT |
| 20:59:39 | $3.79 | 1,667 | $$6K | BUY |
| 20:59:39 | $3.79 | 1,233 | $$5K | SELL |
| 20:59:39 | $3.79 | 1,035 | $$4K | BUY |
5 dark pool trades shown · $$26K preview volume
Real-time institutional flow, block trades, and net positioning
SEPT Investing provides real-time options flow tracking for IVA, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $2.5 | May 21 | 196 | $$255 | 1 | SWEEP |
| CALL | $5 | Nov 20 | 14 | $$85 | 1 | SWEEP |
| CALL | $5 | Nov 20 | 14 | $$85 | 1 | SWEEP |
| CALL | $5 | Nov 20 | 14 | $$425 | 5 | SWEEP |
4 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
SEPT's Trading AI has generated a free, downloadable PDF research report for Inventiva S.A. (IVA) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings intelligence, and a complete investment thesis with entry and exit recommendations.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →Inventiva S.A. (IVA) is at $3.80, up 4.68% (+$0.17) at the Nov 6, 2026 close.
Latest IVA news — Nov 5, 2026: HC Wainwright keeps Buy rating on Inventiva, cuts price target · Nov 5, 2026: HC Wainwright Keeps Buy Rating on Inventiva, Cuts Price Target to $14
The average analyst price target for IVA is $19.50, ranging from $14 to $26, based on 4 analysts. Latest: Piper Sandler maintains on Oct 24, 2026.
Analyst ratings for IVA: 1 Buy, 4 Hold, 0 Sell — consensus Hold.
IVA last reported on Sep 25, 2026: EPS -$0.28 vs -$0.20 expected — a miss of 42.0%.
Support: $3.35, $2.82, $2.23. Resistance: $3.92, $4.27, $4.79.
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
Nov 5, 2026: HC Wainwright keeps Buy rating on Inventiva, cuts price target · Nov 5, 2026: HC Wainwright Keeps Buy Rating on Inventiva, Cuts Price Target to $14 · Oct 24, 2026: Piper Sandler keeps Buy rating and $26 target on Inventiva